Pages that link to "Q57247338"
Jump to navigation
Jump to search
The following pages link to Administration of bone marrow stromal cells ameliorates experimental autoimmune myasthenia gravis by altering the balance of Th1/Th2/Th17/Treg cell subsets through the secretion of TGF-β (Q57247338):
Displayed 45 items.
- Mesenchymal stem cells: environmentally responsive therapeutics for regenerative medicine (Q24632756) (← links)
- Animal models of myasthenia gravis: utility and limitations (Q26750632) (← links)
- Roles of interleukin-21 and its receptor in autoimmune diseases (Q26750745) (← links)
- Enhanced Immunosuppression of T Cells by Sustained Presentation of Bioactive Interferon-γ Within Three-Dimensional Mesenchymal Stem Cell Constructs. (Q33722207) (← links)
- Infusion of bone marrow mononuclear cells reduces lung fibrosis but not inflammation in the late stages of murine silicosis (Q34317667) (← links)
- Inhibition of B-cell proliferation and antibody production by mesenchymal stromal cells is mediated by T cells. (Q34751391) (← links)
- Conditioned mesenchymal stem cells attenuate progression of chronic kidney disease through inhibition of epithelial-to-mesenchymal transition and immune modulation (Q35370283) (← links)
- Chinese medicine bu xu hua yu recipe for the regulation of treg/th17 ratio imbalance in autoimmune hepatitis (Q35568168) (← links)
- Reduced immunomodulation potential of bone marrow-derived mesenchymal stem cells induced CCR4+CCR6+ Th/Treg cell subset imbalance in ankylosing spondylitis (Q35620356) (← links)
- Adipose-Derived Mesenchymal Stem Cells Restore Impaired Mucosal Immune Responses in Aged Mice (Q35912989) (← links)
- Effects of transcutaneous acupoint electrical stimulation on the imbalance of Th1, Th2, Th17 and Treg cells following thoracotomy of patients with lung cancer (Q36524648) (← links)
- Soluble Tumor Necrosis Factor Receptor 1 Released by Skin-Derived Mesenchymal Stem Cells Is Critical for Inhibiting Th17 Cell Differentiation (Q36728560) (← links)
- Mesenchymal stromal cells in transplantation rejection and tolerance (Q36786630) (← links)
- Immunomodulatory effects of mesenchymal stromal cells revisited in the context of inflammatory cardiomyopathy (Q36990126) (← links)
- Intravenous Administration of Adipose-Derived Stem Cell Protein Extracts Improves Neurological Deficits in a Rat Model of Stroke (Q37654417) (← links)
- Delivery of Bone Marrow-Derived Mesenchymal Stem Cells Improves Tear Production in a Mouse Model of Sjögren's Syndrome (Q37703599) (← links)
- The bone marrow stroma in hematological neoplasms--a guilty bystander. (Q37859253) (← links)
- Acetylcholine receptor-induced experimental myasthenia gravis: what have we learned from animal models after three decades? (Q37967185) (← links)
- Dentistry and the myasthenia gravis patient: a review of the current state of the art. (Q38021644) (← links)
- Mesenchymal stromal cells: a key player in 'innate tolerance'? (Q38026931) (← links)
- Mechanisms of mesenchymal stromal cell immunomodulation (Q38054535) (← links)
- Biotechnological and biomedical applications of mesenchymal stem cells as a therapeutic system. (Q38262146) (← links)
- The Immunomodulatory and Therapeutic Effects of Mesenchymal Stromal Cells for Acute Lung Injury and Sepsis (Q38442767) (← links)
- Transcriptional repressor Blimp1 regulates follicular regulatory T cells homeostasis and function. (Q38612353) (← links)
- Implications of mesenchymal stem cells in regenerative medicine (Q38693545) (← links)
- Adipose-Derived Mesenchymal Stem Cells in Autoimmune Disorders: State of the Art and Perspectives for Systemic Sclerosis. (Q38840236) (← links)
- Rejuvenation of mucosal immunosenescence by adipose tissue-derived mesenchymal stem cells (Q39229257) (← links)
- Mesenchymal stem cells and their immunosuppressive role in transplantation tolerance. (Q39430866) (← links)
- Mesenchymal stem cell-derived factors: Immuno-modulatory effects and therapeutic potential (Q39441667) (← links)
- Comparing the immunosuppressive potency of naïve marrow stromal cells and Notch-transfected marrow stromal cells (Q39461500) (← links)
- The effect of stem cell from human exfoliated deciduous teeth on T lymphocyte proliferation (Q42951008) (← links)
- Mesenchymal stem cells (MSCs) from scleroderma patients (SSc) preserve their immunomodulatory properties although senescent and normally induce T regulatory cells (Tregs) with a functional phenotype: implications for cellular-based therapy. (Q43871288) (← links)
- Mesenchymal stem cells: A double-edged sword in radiation-induced lung injury (Q47566394) (← links)
- Molecular and Cellular Mechanisms Involved in Mesenchymal Stem Cell-Based Therapy of Inflammatory Bowel Diseases. (Q48234353) (← links)
- Human embryonic mesenchymal stem cells alleviate pathologic changes of MRL/Lpr mice by regulating Th7 cell differentiation (Q50479906) (← links)
- Mesenchymal Stem Cells Attenuate the Adverse Effects of Immunosuppressive Drugs on Distinct T Cell Subopulations. (Q50733062) (← links)
- Neutralization of interleukin-9 ameliorates symptoms of experimental autoimmune myasthenia gravis in rats by decreasing effector T cells and altering humoral responses. (Q51733444) (← links)
- Systemic infusion of bone marrow-derived mesenchymal stem cells for treatment of experimental colitis in mice. (Q54302606) (← links)
- CTLA-4 methylation regulates the pathogenesis of myasthenia gravis and the expression of related cytokines (Q56892557) (← links)
- Opposing effect of mesenchymal stem cells on Th1 and Th17 cell polarization according to the state of CD4+ T cell activation (Q85121641) (← links)
- Muscle Stem/Progenitor Cells and Mesenchymal Stem Cells of Bone Marrow Origin for Skeletal Muscle Regeneration in Muscular Dystrophies (Q88046702) (← links)
- Defects of CTLA-4 Are Associated with Regulatory T Cells in Myasthenia Gravis Implicated by Intravenous Immunoglobulin Therapy (Q90147393) (← links)
- MSC: immunoregulatory effects, roles on neutrophils and evolving clinical potentials (Q91940433) (← links)
- Mesenchymal Stromal Cells Induce Podocyte Protection in the Puromycin Injury Model (Q92162877) (← links)
- Biological Considerations in Scaling Up Therapeutic Cell Manufacturing (Q96303206) (← links)